COVID Vaccine Strain Changes Could Be Made By US FDA Ahead Of WHO Recommendation

 
• By Brenda Sandburg

Influenza vaccine strain change process could provide framework to update composition of COVID-19 vaccines, agency says. Advisory committee to discuss when changes could be supported by manufacturing information alone, and timing and populations for use of additional boosters.

Vaccine strain
FDA hones in on process to change COVID-19 vaccine composition • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers